Auriga
Auriga USA is a research and trading platform that focuses on growth sectors within the Health Care and Technology verticals. We operate out of our main office in New York City, and also have satellite offices in Boston, San Francisco, Philadelphia, San Diego, and Washington D.C. This regional network helps us to keep abreast of key corporate developments, enhance client relationships, and provide more efficient product distribution to meet clients' investment needs. The firm is committed to providing our clients with critical information flow, investment ideas, and access to industry experts.
-
Auriga Maintains a 'Buy' on EZchip Semiconductor (EZCH); JNPR MX Sales Positive, but NP-4 Ramp Likely Delayed
-
Auriga Reiterates a 'Buy' on EZchip Semiconductor (EZCH); Inventory Correction Drives Big Guidance Shortfall, But Growth Story Is Intact
-
Auriga Maintains a 'Buy' on EZchip Semiconductor (EZCH); Guidance Might Be Light, but We Are Buyers for the Long Term
-
Auriga Raises Price Target on EZchip Semiconductor (EZCH), Maintains Buy Rating
-
Auriga Downgrades Cavium Networks (CAVM) to Hold
-
Notable Analyst Rating Changes 12/06: CSCO, TER, CML, SD Upgraded; ARO, SNDK, GTI, WAG Downgraded
-
Auriga Starts EZchip Semiconductor (EZCH) at Buy
